Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Infusion site reaction
ADR ID BADD_A05364
ADR Hierarchy
08      General disorders and administration site conditions
08.02      Administration site reactions
08.02.05      Infusion site reactions
08.02.05.005      Infusion site reaction
12      Injury, poisoning and procedural complications
12.07      Administration site reactions
12.07.05      Infusion site reactions
12.07.05.006      Infusion site reaction
Description Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA. [MeSH]
MedDRA Code 10054996
MeSH ID D000075662
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Infusion site reaction | Infusion site maceration | Infusion site muscle reaction | Injection Site Reaction | Injection Site Reactions | Injection Site Event | Injection Site Events | Injection Site Adverse Event | Infusion Site Reaction | Infusion Site Reactions | Infusion Site Adverse Reaction | Infusion Site Adverse Event
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01165Insulin lispro--
BADD_D01182Iopromide--
BADD_D01275Levofloxacin0.000186%
BADD_D01381Mepact--
BADD_D01433Methylprednisolone0.000048%
BADD_D01467Milrinone--
BADD_D01468Milrinone lactate--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01569Nimodipine--
BADD_D01623Oritavancin--
BADD_D01633Oxaliplatin0.000414%
BADD_D01653Paclitaxel--
BADD_D01661Pamidronate disodium--
BADD_D01662Pamidronic acid--
BADD_D01789Plerixafor octahydrochloride--
BADD_D01834Prednisone--
BADD_D01923Remifentanil hydrochloride--
BADD_D02110Taliglucerase alfa--
BADD_D02143Telavancin--
BADD_D02268Treprostinil0.001012%
BADD_D02269Treprostinil sodium--
BADD_D02392Zoledronic acid0.009734%
BADD_D02588Remdesivir0.002343%
The 2th Page    First    Pre   2    Total 2 Pages